Empowering Women’s Health: First Lady Jill Biden and Biopharma Leaders Unite at JPM25

JPM25 Conference:
The 43rd Annual J.P. Morgan Healthcare Conference took place from January 13-16, 2025, in San Francisco, CA, connecting global healthcare and life sciences industry leaders, emerging companies, and the investment community14.

First Lady Jill Biden's Address:
First Lady Jill Biden emphasized the need for improved women's health research at Fierce JPM Week 2025. She highlighted the White House Initiative on Women’s Health Research, which has led to significant investments in women’s health research, including $200 million from the National Institutes of Health and $500 million from the Department of Defense25.

Women's Health Market Growth:
The women’s health market is expected to grow from $9 billion to $29 billion in eight years, driven by increased focus on addressing unmet health needs of women2.

Private Sector Involvement:
First Lady Jill Biden called for the private sector to bring discoveries to market and into the hands of consumers, emphasizing the potential for life-saving innovations in women’s health2.

McKinsey Insights:
McKinsey & Company hosted invitation-only events during the conference to discuss pressing challenges and opportunities in the healthcare and life sciences sectors, including AI, women’s health, and care for underserved populations1.

Sources:

1. https://www.mckinsey.com/industries/healthcare/our-insights/jp-morgan-healthcare-conference-and-mckinsey

2. https://www.whitehouse.gov/briefing-room/speeches-remarks/2025/01/14/remarks-as-prepared-for-delivery-by-first-lady-jill-biden-at-fierce-jpm-week-2025/

4. https://thebiocalendar.com/event/the-43rd-jpm-healthcare-conference/

5. https://www.fiercehealthcare.com/regulatory/jpm25-first-lady-jill-biden-committed-improving-womens-health-white-house-tenure-winds